UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$494M |
| 2 |
Johnson & Johnson
JNJ
|
+$466M |
| 3 |
Procter & Gamble
PG
|
+$299M |
| 4 |
Amazon
AMZN
|
+$285M |
| 5 |
Advanced Micro Devices
AMD
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$510M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$315M |
| 4 |
Intel
INTC
|
+$227M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.22% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Financials | 11.23% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Texas Capital Bancshares
TCBI
$4.31B
| $3.86M | ﹤0.01% |
59,801
-108,301
| -64% | -$6.24M |
|
|
MRTX
1327
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.85M | ﹤0.01% |
65,534
-232,660
| -78% | -$13.1M |
|
|
PPBI
1328
DELISTED
Pacific Premier Bancorp
PPBI
| $3.84M | ﹤0.01% |
132,039
+11,606
| +10% | +$270K |
|
|
HCP
1329
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $3.83M | ﹤0.01% |
162,108
-57,532
| -26% | -$1.25M |
|
1330
Acadia Pharmaceuticals
ACAD
$5.04B
| $3.83M | ﹤0.01% |
122,348
+3,605
| +3% | +$86.1K |
|
|
COOP
1331
DELISTED
Mr. Cooper
COOP
| $3.82M | ﹤0.01% |
58,704
-3,786
| -6% | -$224K |
|
1332
Belden
BDC
$5.26B
| $3.82M | ﹤0.01% |
49,479
| – | – |
|
1333
Revolution Medicines
RVMD
$44.1B
| $3.82M | ﹤0.01% |
133,174
+28,936
| +28% | +$695K |
|
1334
Carpenter Technology
CRS
$28B
| $3.81M | ﹤0.01% |
53,876
-3,436
| -6% | -$231K |
|
|
MZTI
1335
The Marzetti Company
MZTI
$3.14B
| $3.8M | ﹤0.01% |
22,864
+554
| +2% | +$93.1K |
|
1336
Helen of Troy
HELE
$667M
| $3.8M | ﹤0.01% |
31,445
+222
| +0.7% | +$23.9K |
|
1337
Minerals Technologies
MTX
$2.31B
| $3.8M | ﹤0.01% |
53,242
+574
| +1% | +$34K |
|
|
AXNX
1338
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.79M | ﹤0.01% |
60,952
+8,249
| +16% | +$461K |
|
1339
Cathay General Bancorp
CATY
$4.22B
| $3.79M | ﹤0.01% |
85,067
+2,323
| +3% | +$87.1K |
|
1340
NCR Voyix
VYX
$1.12B
| $3.79M | ﹤0.01% |
224,017
-144,859
| -39% | -$2.31M |
|
1341
Allegro MicroSystems
ALGM
$8.03B
| $3.77M | ﹤0.01% |
124,502
+7,563
| +6% | +$216K |
|
1342
ACI Worldwide
ACIW
$5.32B
| $3.76M | ﹤0.01% |
122,987
+5,528
| +5% | +$138K |
|
1343
iRhythm Holdings
IRTC
$4.12B
| $3.74M | ﹤0.01% |
34,978
+1,117
| +3% | +$97.3K |
|
1344
Academy Sports + Outdoors
ASO
$3.05B
| $3.73M | ﹤0.01% |
56,565
+2,499
| +5% | +$127K |
|
1345
FTAI Aviation
FTAI
$22.2B
| $3.73M | ﹤0.01% |
80,308
+2,353
| +3% | +$93.9K |
|
1346
LCI Industries
LCII
$2.54B
| $3.71M | ﹤0.01% |
29,538
+343
| +1% | +$39.5K |
|
1347
Blackstone Mortgage Trust
BXMT
$2.35B
| $3.71M | ﹤0.01% |
174,358
-250
| -0.1% | -$5.39K |
|
|
HI
1348
DELISTED
Hillenbrand
HI
| $3.71M | ﹤0.01% |
77,491
| – | – |
|
1349
Grocery Outlet
GO
$960M
| $3.68M | ﹤0.01% |
136,609
+18,028
| +15% | +$505K |
|
|
PCH
1350
DELISTED
PotlatchDeltic
PCH
| $3.66M | ﹤0.01% |
74,622
-15,114
| -17% | -$692K |
|
Similar funds
UBS AM's Q4 2023 Portfolio in Review
As of Q4 2023, UBS AM held 2,644 positions worth $254B, up 14% from $223B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q4 2023 filing shows 62 new, 1,338 increased, 675 reduced and 106 closed positions. Its largest new stake was Veralto: 1,187,566 shares worth $97.7M. The largest sale was VMware, Inc, an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- UBS AM's largest Q4 2023 buy was Veralto: 1,187,566 shares worth $97.7M.
- UBS AM added most to Broadcom in Q4 2023, an estimated $494M increase.
- UBS AM's biggest Q4 2023 reduction was Microsoft, cutting an estimated $315M.
- UBS AM fully exited VMware, Inc in Q4 2023, selling an estimated $510M.
- UBS AM's ten largest holdings make up 26% of its $254B portfolio in Q4 2023.
- UBS AM opened 62 new positions and closed 106 in Q4 2023.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $254B.
Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.